Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052078 · ClinicalTrials.gov registry record · Phase 3
Child and Adolescent Anxiety Disorders (CAMS)
A Phase 3 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 488
- Enrollment target
NCT00052078: Completed Phase 3 study, sponsored by Johns Hopkins University.
NCT00052078 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 488 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00052078, a Phase 3 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 488 participants
- Enrollment target
Study Summary
This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.
Interventions
- DRUG Placebo
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- DRUG Sertraline (SRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052078
The ClinicalTrials.gov registry entry for NCT00052078 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00052078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00052078 about?
NCT00052078 is a clinical study titled "Child and Adolescent Anxiety Disorders (CAMS)". This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.
What is the current status of trial NCT00052078?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 488 participants. The study started on 2003-01. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00052078?
The interventions under investigation include: Placebo (DRUG), Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Sertraline (SRT) (DRUG).
Who is sponsoring clinical trial NCT00052078?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.